Obalon Therapeutics, Inc.

Reshape Lifesciences Inc.

Amy Dl VandenBerg

Mark C Brister

Neil R Drake

Antonio C Llevares

Andrew P Rasdal

Dubravka Markovic

Nelson Quintana

Kaushik Aroonkumar Patel

Sheldon Nelson

Daniel J Proctor

Betty Wong

Keoni John Sundseth

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.

Systems and methods for determining failure of intragastric devices

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Intragastric device

Growing community of inventors

San Diego, CA, United States of America

Amy Dl VandenBerg